HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe

Arthritis Foundation Advocates to Support Arthritis Prevention, Control and Cure Act Introduced at Capitol

February 1, 2007 by HME Business

Arthritis Foundation advocates will converge on Capitol Hill Tuesday and Wednesday (Feb. 27 and 28) to urge the U.S. Congress to support the Arthritis Prevention, Control and Cure Act (S. 626) introduced last week. The legislation is the first comprehensive federal response to the burden of arthritis in more than 30 years. Advocates also will encourage Congress to invest in biomedical research and public health strategies, and increase efforts to confront a disease that affects 46 million Americans, including 300,000 children.


The legislation comes at a critical time, with the prevalence of arthritis continuing to rise due to the aging baby boomer population. In addition to the pain and suffering caused by the disease, arthritis also exacts a hefty financial toll. In 2003 (the most recent statistics available from the Centers for Disease Control and Prevention), arthritis costs to the U.S. economy reached $128 billion.


“We must work together to raise awareness of the seriousness of this devastating disease, while at the same time encouraging our leaders to commit more to arthritis research,” said John H. Klippel, M.D., president and CEO of the Arthritis Foundation. “The Arthritis Prevention, Control and Cure Act offers new hope to the millions of Americans and families living with arthritis as we work to learn more about its causes, develop innovative treatment options and eventually find a cure.”


Currently, National Institutes of Health funding amounts to less than $8 per person with arthritis. Funding for arthritis research has steadily declined since 2003, despite the year-over-year increases in people diagnosed with arthritis. At the same time, federal appropriations for the public health efforts to help prevent arthritis and further disability have leveled off.


The Arthritis Prevention, Control and Cure Act expands the federal government’s efforts to prevent, treat and find a cure for arthritis. The legislation focuses on three primary areas:


  • Investing in a nationwide public health initiative designed to reduce the pain and disability of arthritis through early diagnosis and effective treatment of the disease.

  • Ensuring the 300,000 children with arthritis in the United States have access to care by addressing the nationwide shortage of pediatric rheumatologists (many states do not have a single pediatric rheumatologist to provide care to children in need).

  • Improving coordination among federal agencies and the public with regard to the federal investment in arthritis research and public health activities through the formation of an Arthritis Interagency Coordinating Committee.


The Arthritis Prevention, Control and Cure Act (S. 626) was introduced by Sen. Edward Kennedy (D-Mass.), the chairman of the Senate Health, Education and Labor Committee, and Sen. Kit Bond (R-Mo.).

Related Articles Read More >

AAHomecare: Competitive Bidding Won’t Feature ‘Legacy’ Product Categories
CQRC ‘Commends’ Exclusions of Supplemental Oxygen, CPAP from Medicare Competitive Bidding
The Council for Quality Respiratory Care also urged industry support for the SOAR act.
AOPA: Final Rule to Have ‘Significant Impact’ on Orthotics, Prosthetics Providers
OTS knee, spinal and upper-extremity orthoses are included in the remote item delivery portion of the competitive bidding program.
Resmed Announces FDA Clearance for AI Device to Support Sleep Therapy Regimens
The device incorporates artificial intelligence and will be marketed as Smart Comfort.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe